Table: Kobayashi Pharmaceutical -2019 group results

Kobayashi Pharmaceutical

31/01/2020 06:00

Jan 31 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2019    Dec 31, 2018   Dec 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            168.05          167.48         165.00                 
                 (+0.3 pct)      (+6.8 pct)                              
  Operating         26.36           26.29          26.40                 
                 (+0.3 pct)      (+14.7 pct)                             
  Recurring         27.85           27.37          28.00                 
                 (+1.7 pct)      (+13.2 pct)                             
  Net                                              20.00                 
  Net               19.14           18.02                                
                 (+6.2 pct)      (+13.6 pct)                             
  EPS            244.08 yen      228.05 yen     255.88 yen               
  EPS Diluted                    227.95 yen                              
  Ann Div         73.00 yen       66.00 yen      75.00 yen               
  -Q2 Div         33.00 yen       31.00 yen      34.00 yen               
  -Q4 Div         40.00 yen       35.00 yen      41.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T